XML 30 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

14. Stock-Based Compensation

Restricted Stock Units

Restricted stock units (RSUs) activity for the six months ended June 30, 2024 is as follows:

 

 

Number of
Shares

 

 

Weighted-
Average
Grant Date Fair
Value

 

Balance, December 31, 2023

 

 

3,244,369

 

 

$

5.30

 

RSUs granted

 

 

7,172,708

 

 

 

0.17

 

RSUs vested

 

 

(5,125,758

)

 

 

1.09

 

RSUs canceled

 

 

(958,001

)

 

 

4.15

 

Balance, June 30, 2024

 

 

4,333,318

 

 

$

2.06

 

 

Stock Options

Stock option activity for the six months ended June 30, 2024 (in thousands, except share amounts and per unit data) is as follows:

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

 

Aggregate
Intrinsic
Value

 

Balance, December 31, 2023

 

 

7,997,004

 

 

$

1.78

 

 

 

7.53

 

 

$

10

 

Options granted

 

 

92,447,500

 

 

 

0.25

 

 

 

9.67

 

 

 

 

Options exercised

 

 

(52,557

)

 

 

0.03

 

 

 

 

 

 

6

 

Options expired

 

 

(183,793

)

 

 

4.29

 

 

 

 

 

 

1

 

Options forfeited

 

 

(1,732,576

)

 

 

1.05

 

 

 

 

 

 

 

Balance, June 30, 2024

 

 

98,475,578

 

 

$

0.35

 

 

 

9.40

 

 

$

4

 

Vested and Exercisable,
   June 30, 2024

 

 

4,063,544

 

 

 

2.34

 

 

 

3.80

 

 

 

3

 

Vested and Exercisable and Expected to Vest,
   June 30, 2024

 

 

98,475,578

 

 

$

0.35

 

 

 

9.40

 

 

$

4

 

 

The intrinsic value is calculated as the difference between the exercise price of the underlying stock option award and the estimated fair value of the Company’s common stock. The total intrinsic value for stock options exercised during the six months ended June 30, 2024 and 2023 was $6.0 thousand and $1.0 thousand, respectively. The fair value of awards vested during the six months ended June 30, 2024 and 2023 was $1.2 million and $2.8 million, respectively. The weighted-average grant-date fair value per share of stock options granted during the six months ended June 30, 2024 and 2023 was $0.17 and $0.18, respectively.

The following table summarizes the weighted-average assumptions used in the valuation of stock options granted:

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

Expected volatility (%)

 

 

71.3

%

 

 

81.4

%

Risk-free interest rate (%)

 

 

4.3

%

 

 

3.6

%

Expected dividend yield

 

 

 

 

 

 

Expected term (years)

 

 

6.8

 

 

 

6.0

 

 

 

The Company recognized stock-based compensation expense related to stock options of $2.5 million and $0.8 million for the three months ended June 30, 2024 and 2023, respectively, and $3.8 million and $2.0 million for the six months ended June 30, 2024 and 2023, respectively. This expense was included in the consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Sales and marketing

 

$

6

 

 

$

15

 

 

$

14

 

 

$

32

 

Operations

 

 

39

 

 

 

177

 

 

 

141

 

 

 

367

 

Technology and product development

 

 

66

 

 

 

97

 

 

 

130

 

 

 

207

 

General and administrative

 

 

2,371

 

 

 

560

 

 

 

3,497

 

 

 

1,394

 

Total

 

$

2,482

 

 

$

849

 

 

$

3,782

 

 

$

2,000

 

 

As of June 30, 2024, there was $16.0 million of total unrecognized compensation cost related to unvested stock options granted under the plan that is expected to be recognized over a weighted-average period of 3.19 years.

The Company recognized stock-based compensation expense related to RSUs of $1.6 million and $2.0 million for the three months ended June 30, 2024 and 2023, respectively, and $3.6 million and $4.4 million for the six months ended June 30, 2024 and 2023, respectively. This expense was included in the consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Sales and marketing

 

$

78

 

 

$

106

 

 

$

162

 

 

$

221

 

Operations

 

 

270

 

 

 

442

 

 

 

575

 

 

 

1,071

 

Technology and product development

 

 

799

 

 

 

991

 

 

 

1,596

 

 

 

1,889

 

General and administrative

 

 

483

 

 

 

452

 

 

 

1,296

 

 

 

1,224

 

Total

 

$

1,630

 

 

$

1,991

 

 

$

3,629

 

 

$

4,405

 

 

As of June 30, 2024, there was $8.1 million of total unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted-average period of 1.19 years.